To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease
Clinical trial NCT07422311 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07422311
- Sponsor
- Benuvia Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-05-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.